Our previous work demonstrated that B cell-specific expression of a mutated Receptor Activator of NF-κB (RANKK240), identified in human diffuse large B cell lymphoma (DLBCL) patients26, triggers autoimmune disease in mice (RK mice). Here, TNFRSF11A is linked to diffuse large B-cell lymphoma.